Alpha-smooth muscle actin-expressing dermal sheath cells are a major cellular contributor to heterotopic subcutaneous ossifications in a mouse model of Albright hereditary osteodystrophy

Heterotopic ossifications (HOs) are the pathologic process by which bone inappropriately forms outside of the skeletal system. Despite HOs being a persistent clinical problem in the general population, there are no definitive strategies for their prevention and treatment due to a limited understanding of the cellular and molecular mechanisms contributing to lesion development. One disease in which the development of heterotopic subcutaneous ossifications (SCOs) leads to morbidity is Albright hereditary osteodystrophy (AHO). Albright hereditary osteodystrophy is caused by heterozygous inactivation of <i>GNAS</i>, the gene that encodes the α-stimulatory subunit (Gα<sub>s</sub>) of G proteins. Previously, we had shown using our laboratory's AHO mouse model that SCOs develop around hair follicles. Here we show that SCO formation occurs due to inappropriate expansion and osteogenic differentiation of cells that express alpha-smooth muscle actin and that are located within the dermal sheath. We also show in AHO patients and mice that <i>secreted frizzled related protein 2</i> (<i>SFRP2)</i> expression is upregulated in regions of SCO formation and that elimination of <i>Sfrp2</i> in male AHO mice leads to earlier development, greater severity, and acceleration of formation of SCOs. These studies provide key insights into the cellular and molecular mechanisms contributing to SCO development and have implications for potential therapeutic modalities not only for AHO patients but also for patients suffering from HOs with other etiologies.

Authors

Institutions

Publication Details

Journal
JBMR Plus
Published
2025-02-27
DOI
https://doi.org/10.1093/jbmrpl/ziaf038
Primary Topic
Heterotopic Ossification and Related Conditions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alpha-smooth muscle actin-expressing dermal sheath cells are a major cellular contributor to heterotopic subcutaneous ossifications in a mouse model of Albright hereditary osteodystrophy

Peter Maye, Qingfen Yang, Emily L. Germain‐Lee, Sarah Edie et al.
JBMR Plus
Heterotopic Ossification and Related Conditions
article

Alpha-smooth muscle actin-expressing dermal sheath cells are a major cellular contributor to heterotopic subcutaneous ossifications in a mouse model of Albright hereditary osteodystrophy

Peter Maye, Qingfen Yang, Emily L. Germain‐Lee, Sarah Edie, Ivo Kalajzić, David Rowe, Patrick McMullan, Sierra H. Root
article en

Abstract

Heterotopic ossifications (HOs) are the pathologic process by which bone inappropriately forms outside of the skeletal system. Despite HOs being a persistent clinical problem in the general population, there are no definitive strategies for their prevention and treatment due to a limited understanding of the cellular and molecular mechanisms contributing to lesion development. One disease in which the development of heterotopic subcutaneous ossifications (SCOs) leads to morbidity is Albright hereditary osteodystrophy (AHO). Albright hereditary osteodystrophy is caused by heterozygous inactivation of <i>GNAS</i>, the gene that encodes the α-stimulatory subunit (Gα<sub>s</sub>) of G proteins. Previously, we had shown using our laboratory's AHO mouse model that SCOs develop around hair follicles. Here we show that SCO formation occurs due to inappropriate expansion and osteogenic differentiation of cells that express alpha-smooth muscle actin and that are located within the dermal sheath. We also show in AHO patients and mice that <i>secreted frizzled related protein 2</i> (<i>SFRP2)</i> expression is upregulated in regions of SCO formation and that elimination of <i>Sfrp2</i> in male AHO mice leads to earlier development, greater severity, and acceleration of formation of SCOs. These studies provide key insights into the cellular and molecular mechanisms contributing to SCO development and have implications for potential therapeutic modalities not only for AHO patients but also for patients suffering from HOs with other etiologies.

JBMR PlusVol. 9(5)
University of Connecticut (US), Connecticut Children's Medical Center (US), Jackson Laboratory (US), UConn Health (US)
Johns Hopkins University, University of Connecticut Health Center, National Institutes of Health, National Institute of Dental and Craniofacial Research
Openalex Percentile: Top 88%
Heterotopic Ossification and Related Conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.